tiprankstipranks
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
US Market

Bolt Biotherapeutics (BOLT) Financial Statements

Compare
213 Followers

Bolt Biotherapeutics Financial Overview

Bolt Biotherapeutics's market cap is currently $19.52M. The company's EPS TTM is $-1.708; its P/E ratio is ―; Bolt Biotherapeutics is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 7.88M$ 5.73M$ 1.26M$ 231.00K$ 215.00K
Gross Profit$ 5.99M$ 838.00K$ -2.41M$ -40.13M$ -25.79M
Operating Income$ -76.20M$ -90.32M$ -92.79M$ -49.18M$ -30.97M
EBITDA$ -74.34M$ -88.66M$ -91.59M$ -48.57M$ -30.63M
Net Income$ -69.20M$ -85.88M$ -104.39M$ -72.27M$ -30.00M
Balance Sheet
Cash & Short-Term Investments$ 102.19M$ 168.89M$ 186.22M$ 22.84M$ 34.83M
Total Assets$ 159.78M$ 227.81M$ 307.72M$ 46.54M$ 48.45M
Total Debt$ 20.22M$ 22.61M$ 24.36M$ 10.88M$ 10.19M
Net Debt$ 9.41M$ 13.37M$ -3.03M$ 5.33M$ -24.64M
Total Liabilities$ 47.04M$ 56.30M$ 57.60M$ 151.49M$ 94.29M
Stockholders' Equity$ 112.74M$ 171.51M$ 250.12M$ -104.95M$ -45.85M
Cash Flow
Free Cash Flow$ -69.73M$ -78.46M$ -59.40M$ -50.57M$ -26.85M
Operating Cash Flow$ -69.53M$ -76.50M$ -57.07M$ -47.31M$ -26.34M
Investing Cash Flow$ 71.04M$ 57.86M$ -232.20M$ -20.59M$ -508.00K
Financing Cash Flow$ 253.00K$ 503.00K$ 311.11M$ 39.60M$ 48.63M
Currency in USD

Bolt Biotherapeutics Earnings and Revenue History

Bolt Biotherapeutics Debt to Assets

Bolt Biotherapeutics Cash Flow

Bolt Biotherapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis